Fenofibrate and telmisartan in the management of abdominal aortic aneurysm.

Conclusions Fenofibrate and telmisartan have potential as repurposed medications to limit AAA growth and randomized trials for further assessment in AAA patients are ongoing. PMID: 29284388 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29284388?dopt=Abstract

Source: Current Drug Targets - December 27, 2017 Category: Drugs & Pharmacology Authors: Rowbotham SE, Krishna SM, Moran CS, Golledge J Tags: Curr Drug Targets Source Type: research